Guru Ownership Trend
Guru Analysis for Collegium Pharmaceutical, Inc. (COLL)
Collegium Pharmaceutical, Inc. (COLL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $46.74 M.
Top institutional holders include Renaissance Technologies (RenTech) and Chuck Royce.
Institutional sentiment is currently Bullish. This is evidenced by a $8,232.29 net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 7.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Collegium Pharmaceutical, Inc. (COLL)
Major holders include Renaissance Technologies (RenTech) ($49.47 M), Chuck Royce ($12.02 M), Cliff Asness ($5.42 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.07 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8,232.29, with 5 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited COLL. The total reported sell value was $7.66 M.
Yes, 1 managers opened new positions in COLL, and 4 increased their existing holdings. The total reported buy value was $7.67 M.